Allarity Therapeutics
Price & Volume
Stats
See more52W Range | $0.67-$174 |
Market Cap | $2M |
Shares Short | 478,562 |
Financials
See moreRevenue (12 Mos) | -$7.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$36.3M |
Diluted EPS | -$10.98 |
News
See moreYahoo Finance • 3 days ago
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Yahoo Finance • 21 days ago
Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission
Yahoo Finance • 28 days ago
Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration
Yahoo Finance • last month
Allarity Therapeutics Announces Dismissal of Securities Class Action Lawsuit
About
CEO | Mr. Thomas H. Jensen |
Address | 24 School Street, Boston, MA, United States, 02108 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |
